Log in om verder te lezen.
Alleen abonnees van het Pharmaceutisch Weekblad hebben volledige toegang tot pw.nl. Meer informatie over een abonnement op PW.
Price orphan drugs can be reduced drastically
Skyrocketing healthcare costs need to be held in check
Better diagnostic testing allows tailored therapy for an increasing number of diseases. This has led to a growing number of conditions classified as ‘orphan diseases’. A welcome source of income for the pharmaceutical industry, but a growing expense for society. It’s time for a change of course.
